Venture Partner at Thuja Capital
Check size: Thuja Capital does not publish a standard check-size range on its current official site.
Florian Ludwig invests or supports investment decisions through Thuja Capital's published strategy: Back European biotech and medtech founders translating scientific breakthroughs into products that can reach patients and improve healthcare.
Show the unmet need, scientific evidence, IP position, development and regulatory plan, team capability, capital requirements and path to patient impact.
Strong science, differentiated intellectual property, experienced teams and a credible path from laboratory validation to clinical and commercial impact.
The published strategy centers on European early-stage biotech and medtech; opportunities outside life sciences or without defensible science are less aligned.